rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2002-8-7
|
pubmed:abstractText |
2-year results of a German multicenter randomized trial showed that accelerated chemoradiation with MMC/5-FU to 70.6 Gy is more effective than accelerated radiation to 77.6 Gy alone at equivalent levels of acute and late radiation morbidity. Frequency, histopathology and impact on local tumor control of selective lymph node dissection were analyzed.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0179-7158
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
178
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
363-8
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:12163990-Adult,
pubmed-meshheading:12163990-Aged,
pubmed-meshheading:12163990-Aged, 80 and over,
pubmed-meshheading:12163990-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12163990-Carcinoma, Squamous Cell,
pubmed-meshheading:12163990-Combined Modality Therapy,
pubmed-meshheading:12163990-Dose Fractionation,
pubmed-meshheading:12163990-Female,
pubmed-meshheading:12163990-Fluorouracil,
pubmed-meshheading:12163990-Humans,
pubmed-meshheading:12163990-Lymph Node Excision,
pubmed-meshheading:12163990-Lymphatic Metastasis,
pubmed-meshheading:12163990-Male,
pubmed-meshheading:12163990-Middle Aged,
pubmed-meshheading:12163990-Mitomycin,
pubmed-meshheading:12163990-Neoadjuvant Therapy,
pubmed-meshheading:12163990-Otorhinolaryngologic Neoplasms,
pubmed-meshheading:12163990-Radiation Dosage,
pubmed-meshheading:12163990-Survival Rate
|
pubmed:year |
2002
|
pubmed:articleTitle |
Selective lymph node dissection following hyperfractionated accelerated radio-(chemo-)therapy for advanced head and neck cancer.
|
pubmed:affiliation |
Department of Radiation Oncology, Eberhard-Karls University of Tübingen, Germany. thomas.hehr@med.uni-tuebingen.de
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|